NCT06175195

Brief Summary

The main objective of the study are:

  1. 1.To explore the effectiveness of psychoeducation program for cancer patients who refuse treatment because of irrational fears and anxieties.
  2. 2.To explore the effectiveness of psychoeducation program for cancer patients who have negative attitudes, and low motivation toward treatment which causes depression and affects the quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2023

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

November 23, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2024

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

3 months

First QC Date

November 23, 2023

Last Update Submit

December 8, 2023

Conditions

Keywords

Psychoeducational Program.Treatment refusalDepressive symptomsAnxietyHelp-seeking attitudeCancer Patients

Outcome Measures

Primary Outcomes (5)

  • Treatment Refusal

    Initially, we will enroll the patients for eligibility assessment and the eligible patients who are refusing medical (Chemotherapy, Radiation and Surgery) and psychological treatment (Counseling, psychotherapy) will be referred for psychological evaluations

    3-5 weeks

  • Depression and Anxiety

    Depression will be assessed by using Patient Health Questionnaire-9. A Score of 5, 10, 15, and 20 correspond to categorizations of mild, moderate, moderately severe, and severe depression respectively. Hospital Anxiety and Depression will be assessed by using Hospital Anxiety and Depression Scale. A score of 0-7 is considered normal, 8-10 as borderline and 11-21 as either anxious or depressed

    after allocation (1 week)

  • Illness denial

    Illness denial will be assessed by using Illness Denial Questionnaire. Higher score indicate high Illness denial whereas low score indicate low illness denial.

    after allocation (1 week)

  • Motivation and Help-Seeking attitude

    Motivation will be assessed by using Motivation and attitude towards changing health Scale. Higher score indicate higher motivation whereas low score indicate low motivation. Mental Help seeking attitude will be assessed by using Mental Help Seeking Attitude Scale. Higher score indicate high mental help seeking attitude whereas low score indicate low mental help seeking attitude.

    after allocation (1 week)

  • Quality of Life Scale

    Quality of Life will be measured by World Health Organization Quality of Life BREF. Higher score indicate high quality of life whereas low score indicate low quality of life

    after allocation (1 week)

Secondary Outcomes (2)

  • Duration of illness

    at the time of pre assessment (1 week)

  • stage of cancer

    after allocation at pre-assessment (1 week)

Study Arms (2)

Treatment Group

EXPERIMENTAL

Experimental Group: Participants in the experimental group would receive 8-10 session of psychoeducational based Program. Waitlist control Group: Participants in the Control group would not receive psychoeducational Intervention.

Behavioral: Psychoeducational Inervention

Control Group

NO INTERVENTION

Control Group: Participants in the control group did not receive the said psychoeducational intervention.

Interventions

Psychoeducational Program would be used as an intervention stratégie for cancer patients to provide understanding and insight to the patients about the problems. Further, this program would address treatment refusal and illness denial, depressive symptoms, and treatment related irrational fears and anxiety. Moreover, this program will improve patients' motivation and attitude toward changing health, and quality of life.

Treatment Group

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants who will be diagnosed with cancer at stage-I, II and III and who have refused medical and psychological treatment will be included in the treatment
  • The second eligibility criterion of the participants would be at least mild score on PHD-9 to cross-check the mental health problems Participants they have diagnosed by the consultant after proper medical screening and evaluation will be included
  • The patients would be taken from lower, middle and upper socioeconomic status.
  • Their age range would be from 20-70 years.

You may not qualify if:

  • Participants with medical and psychiatric comorbidities will be excluded
  • The patients diagnosed with 4th stage would be excluded. Participants with serious medical condition will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qasir Abbas

Faisalābad, Punjab Province, 38000, Pakistan

Location

MeSH Terms

Conditions

Treatment RefusalDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorBehavioral SymptomsMental Disorders

Study Officials

  • Qasir Abbas, PHD

    Government College University, Faislabad.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized control trial design would be used in this study. It would be two arm study and there would be two groups an experimental and wait-list control group. Experimental group will receive intervention and another group would be placed in waitlist. In this research, parallel group design would be used. We will give treatment to all participants in a parallel way. Allocation ratio and framework would be equivalence i.e., treatment group and control group would be equal number of participants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 23, 2023

First Posted

December 18, 2023

Study Start

November 15, 2023

Primary Completion

February 1, 2024

Study Completion

April 10, 2024

Last Updated

December 18, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations